Preparation and evaluation of iopamidol Parenteral formulation
Parenteral administration offers many advantages over therapy, given by non parenteral routes. Most notably, therapeutics can reliably predict with considerably accuracy, the Pharmacokinetic and Pharmacology of the agents. Despite of these advantages, parenteral administration is not without certain, measurable risks and limitation that the professional must intelligently weigh in terms of risks benefits, and costs. Iopamidol is radio opaque Nonionic contrast media used parenterally for diagnostic purpose. Solubility of iopamidol is very limited in water. Various Marketed formulations suffer the problem of crystallization of Iopamidol; such crystallization is very crucial as it will vary the dose and also effective drug in the solubilized form is minimized.
. Rutten A, Prokop M. Contrast agents in X-ray computed tomography and its applications in oncology. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents). 2007 May 1;7(3):307-16.
. Mckinstry DN, Rommel AJ, Sugerman AA. Pharmacokinetics, Metabolism, and Excretion of Iopamidol in Healthy Subjects. Investigative Radiology. 1984 Sep 1;19(5):S171-174.
. Motola,S., Biopharmaceutics Of Injectables Medication In Pharmaceutical Dosage Form Parenteral Medication, Marcel Dekker, Inc. Vol. 1.(2ND ED)., PP. 59 (1995).
. Kawada TK. Iohexol and iopamidol: second-generation nonionic radiographic contrast media. Drug Intell Clin Pharm Jul/Aug; 19: 525-9. 1985
. Almen T. Contrast media: the relation of chemical structure, animal toxicity and adverse clinical effects. Am J Cardiol; 66: 2F-8F. 1990
. Reagents: Volumetric Solutions - Pharmacopeia.cn Available from URL: www.pharmacopeia.cn/v29240/usp29nf24s0_volumetric-solutions-1345-1360.html
. Atemnkeng MA, Plaizier-Vercammen J, Schuermans A. Comparison of free and bound iodine and iodide species as a function of the dilution of three commercial povidone-iodine formulations and their microbicidal activity. Int J Pharm. 2006 Jul 24; 317(2):161-6.
. Brinker JA. Selection of a contrast agent in the cardiac catheterization laboratory. Am J Cardiol; 66: 26F-33F. 1990
. Swanson DP, Chilton HM, Thrall JH, editors. Pharmaceuticals in medical imaging. New York: MacMillan Publishing Company,: 1-35, 125-54, 253-77. 1990
. Martin FIR, Tress BW, Colman PG, et al. Iodine-induced hyperthyroidism due to nonionic contrast radiography in the elderly. Am J Med; 95: 78-82. 1993
. Isovue (Squibb). In: Krogh CME, editor. CPS Compendium of pharmaceuticals and specialties. 29th ed. Ottawa: Canadian Pharmaceutical Association, 1994: 638.
. Motola, S., Agharkr, S. N., Preformulation Research Of Parenteral Medication in Pharmaceutical Dosage Form Parenteral Medication, Marcel Dekker, Inc. Vol. 1.(2ND ED)., PP. 59 (1995).
. Simonelli, A.P. And Dresback, D.S., In Perspectives In Clinical Pharmacy, Drug Inteligence Publication, Hamilton, Lllinois, PP. 390-420, (1972).
. Kostendauder, H.B., Rapp, R P., Mc. Govren J.P., Foster, T.S. Perrier D.G., Blacker, H.M., Hulon W.C., and Kinkel,A.W., Clinical Pharmacology Ther., 18 PP. 449 (1975)
Copyright (c) 2014 International Journal of Advances in Pharmaceutics
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).